Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

The synthesis of new amide type histone deacetylase inhibitors is described, having an (R)-methyl substituent and a diene or saturated structure of the chain linking the hydroxamic acid and dimethylaminobenzoyl groups. The saturated compound shows stronger HDAC inhibition than the unsaturated analogue. Molecular modeling suggests that the flexibility of the linker chain is important for an optimal orientation of the dimethylaminobenzoyl group in the enzyme.

Knowledge Graph

Similar Paper

Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Bioorganic & Medicinal Chemistry Letters 2003.0
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
European Journal of Medicinal Chemistry 2009.0
Synthesis of rigid trichostatin A analogs as HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: Attenuation of potency through resonance effects
Bioorganic & Medicinal Chemistry Letters 2012.0
Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring
Journal of Medicinal Chemistry 2010.0
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates
Bioorganic & Medicinal Chemistry Letters 2003.0
An azumamide C analogue without the zinc-binding functionality
MedChemComm 2014.0
A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: Design, synthesis and molecular modeling study
European Journal of Medicinal Chemistry 2012.0
Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates
Journal of Medicinal Chemistry 2002.0
Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2003.0